Literature DB >> 12609507

Progressive skeletal myopathy, a phenotypic variant of desmin myopathy associated with desmin mutations.

Marinos C Dalakas1, Ayush Dagvadorj, Bertrand Goudeau, Kye-Yoon Park, Kazuyo Takeda, Monique Simon-Casteras, Olavo Vasconcelos, Nyamkhishig Sambuughin, Alexey Shatunov, James W Nagle, Kumaraswamy Sivakumar, Patrick Vicart, Lev G Goldfarb.   

Abstract

Desmin myopathy is a familial or sporadic disorder characterized by the presence of desmin mutations that cause skeletal muscle weakness associated with cardiac conduction block, arrhythmia and heart failure. Distinctive histopathologic features include intracytoplasmic accumulation of desmin-reactive deposits and electron-dense granular aggregates in skeletal and cardiac muscle cells. We describe two families with features of adult-onset slowly progressive skeletal myopathy without cardiomyopathy. N342D point mutation was present in the desmin helical rod domain in patients of family 1, and I451M mutation was found in the non-helical tail domain in patients of family 2. Of interest, the same I451M mutation has previously been reported in patients with cardiomyopathy and no signs of skeletal myopathy. Some carriers of the I451M mutation did not develop any disease, suggesting incomplete penetrance. Expression studies demonstrated inability of the N342D mutant desmin to form cellular filamentous network, confirming the pathogenic role of this mutation, but the network was not affected by the tail-domain I451M mutation. Progressive skeletal myopathy is a rare phenotypic variant of desmin myopathy allelic to the more frequent cardio-skeletal form.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12609507     DOI: 10.1016/s0960-8966(02)00271-7

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  25 in total

1.  Dual color photoactivation localization microscopy of cardiomyopathy-associated desmin mutants.

Authors:  Andreas Brodehl; Per Niklas Hedde; Mareike Dieding; Azra Fatima; Volker Walhorn; Susan Gayda; Tomo Šarić; Bärbel Klauke; Jan Gummert; Dario Anselmetti; Mike Heilemann; Gerd Ulrich Nienhaus; Hendrik Milting
Journal:  J Biol Chem       Date:  2012-03-08       Impact factor: 5.157

Review 2.  GFAP and its role in Alexander disease.

Authors:  Roy A Quinlan; Michael Brenner; James E Goldman; Albee Messing
Journal:  Exp Cell Res       Date:  2007-04-06       Impact factor: 3.905

3.  Evidence-based guideline summary: diagnosis and treatment of limb-girdle and distal dystrophies: report of the guideline development subcommittee of the American Academy of Neurology and the practice issues review panel of the American Association of Neuromuscular & Electrodiagnostic Medicine.

Authors:  Pushpa Narayanaswami; Michael Weiss; Duygu Selcen; William David; Elizabeth Raynor; Gregory Carter; Matthew Wicklund; Richard J Barohn; Erik Ensrud; Robert C Griggs; Gary Gronseth; Anthony A Amato
Journal:  Neurology       Date:  2014-10-14       Impact factor: 9.910

4.  Clinical and myopathological characteristics of desminopathy caused by a mutation in desmin tail domain.

Authors:  Paul Maddison; Maxwell S Damian; Caroline Sewry; Catherine McGorrian; John B Winer; Zagaa Odgerel; Alexey Shatunov; Hee Suk Lee; Lev G Goldfarb
Journal:  Eur Neurol       Date:  2012-10-05       Impact factor: 1.710

Review 5.  Molecular insights into cardiomyopathies associated with desmin (DES) mutations.

Authors:  Andreas Brodehl; Anna Gaertner-Rommel; Hendrik Milting
Journal:  Biophys Rev       Date:  2018-06-20

6.  Intermediate filament diseases: desminopathy.

Authors:  Lev G Goldfarb; Montse Olivé; Patrick Vicart; Hans H Goebel
Journal:  Adv Exp Med Biol       Date:  2008       Impact factor: 2.622

Review 7.  Insights into the beaded filament of the eye lens.

Authors:  Ming-Der Perng; Qingjiong Zhang; Roy A Quinlan
Journal:  Exp Cell Res       Date:  2007-04-06       Impact factor: 3.905

Review 8.  Distal myopathies.

Authors:  Mazen M Dimachkie; Richard J Barohn
Journal:  Neurol Clin       Date:  2014-05-15       Impact factor: 3.806

9.  A missense mutation in desmin tail domain linked to human dilated cardiomyopathy promotes cleavage of the head domain and abolishes its Z-disc localization.

Authors:  Manolis Mavroidis; Panagiota Panagopoulou; Ioanna Kostavasili; Noah Weisleder; Yassemi Capetanaki
Journal:  FASEB J       Date:  2008-06-06       Impact factor: 5.191

10.  Bcl-2 overexpression corrects mitochondrial defects and ameliorates inherited desmin null cardiomyopathy.

Authors:  Noah Weisleder; George E Taffet; Yassemi Capetanaki
Journal:  Proc Natl Acad Sci U S A       Date:  2004-01-08       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.